ZN-c3 in combination with chemotherapy demonstrated strong anti-tumor activity in a heavily pretreated population, with…
Two Additional Preclinical Proof-of-concept Posters in Ovarian and Metastatic Lung Cancer Models Also Presented at…
Covalent menin inhibitor BMF-219 showed strong cytotoxic activity as a single agent at similar concentrations across…
WTX-124 demonstrated high tumor selectivity and generated significant anti-tumor activity in a CD8+ T cell-dependent…
TET platform shows efficient T cell priming and beneficial safety profile Data supported clinical transition…
ImCheck Provides Updated ICT01 and Pembrolizumab Combination Datafrom the Phase I/IIa EVICTION Trial at AACR…
Riga, Latvia–(Newsfile Corp. – April 8, 2022) – The Bitcoin City project is the metaverse’s…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its RMBS Credit Indices (KCI) for March 2022. The indices track…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its solar loan index publication, providing monthly credit trends of securitized…
BOSTON–(BUSINESS WIRE)–#aacr22—PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, today announced that…
Transgene will discuss new immunogenicity and clinical data generated with TG4050 that reinforce the strong…
NEW YORK–(BUSINESS WIRE)–Kim & Serritella LLP and Barton LLP announce that a securities class action,…
DEINOVE presents its financial results and the advancement of its programs for 2021 Favorable opinion…
Oslo, 08 April 2022: In connection with the Annual General Meeting of Ultimovacs ASA to…
MAINZ, Germany, April 8, 2022 — BioNTech SE (Nasdaq: BNTX) today announced that it is…
RESEARCH TRIANGLE PARK, N.C., April 08, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
DURHAM, N.C., April 08, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
— Anti-PD1-IL-2 BiSKIT (Bi-functional SuperKines for ImmunoTherapy) selectively stimulates anti-cancer immune cells via IL-2 agonism and prevents…
— Fc-MDNA413 suppresses pro-tumor immune pathways by simultaneously inhibiting IL-4 / IL-13 mediated signaling and…
LAS VEGAS, NV, Apr 8, 2022 – (ACN Newswire) – SCCG Management CEO and Founder…